A new level of complexity has recently been added to estrogen signaling wit
h the identification of a second estrogen receptor, ER beta. By screening a
rat prostate cDNA library, we detected ER beta as well as a novel isoform
that we termed ER beta 2. ER beta 2 contains an in-frame inserted exon of 5
4 nucleotides that results in the predicted insertion of 18 amino acids wit
hin the ER beta hormone-binding domain. We also have evidence for the expre
ssion of both ER beta 1 and ER beta 2 in human cell lines. Competition liga
nd binding analysis of bacterially expressed fusion proteins revealed an 8-
fold lower affinity of ER beta 2 for 17 beta-estradiol (E-2) [dissociation
constant (K-d similar to 8 nM)] as compared with ER beta 1 (K-d similar to
1 nM). In vitro transcribed and translated ER beta 1 and ER beta 2 bind spe
cifically to a consensus estrogen responsive element in a gel mobility shif
t assay. Furthermore, we show heterodimerization of ER beta 1 and ER beta 2
with each other as well as with ER alpha. In affinity interaction assays f
or proteins that associate specifically with the hormone-binding domain of
these receptors, we demonstrate that the steroid receptor coactivator SRC-1
interacts in an estrogen-dependent manner with ER alpha and ER beta 1, but
not with ER beta 2. In cotransfection experiments with expression plasmids
for ER alpha, ER beta 1, and ER beta 2 and an estrogen-responsive element-
containing luciferase reporter, the dose response of ER beta 1 to E-2 was s
imilar to that of ER alpha although the maximal stimulation was approximate
ly 50%. In contrast, ER beta 2 required 100- to 1000-fold greater E-2 conce
ntrations for maximal activation. Thus, ER beta 2 adds yet another facet to
the possible cellular responses to estrogen.